Counterpoint Biomedica
ApprovedAdvanced Proprietary Tumor-Targeting Platforms and Precision Cancer Diagnostics
Founded
2019
Focus
Drug Delivery
About
Advanced Proprietary Tumor-Targeting Platforms and Precision Cancer Diagnostics
Funding History
1Total raised: $3.5M
Seed$3.5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2019
LocationSan Diego, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile